Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | POLQ | O75417 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15440067 | 0.93 | ALDH1A1 (0.35) | PKM | |
| SCHEMBL15439517 | 0.77 | PKM (0.32) | PKMPOLQNPSR1CHRM4CHRM3 | |
| SCHEMBL15439520 | 0.77 | PKM (0.32) | PKMPOLQNPSR1CHRM4CHRM3 | |
| SCHEMBL15439705 | 0.77 | NPC1 (0.38) | CHRM4CHRM3 | |
| SCHEMBL15439966 | 0.77 | — | — | |
| SCHEMBL15439913 | 0.75 | — | — | |
| SCHEMBL15440296 | 0.72 | G6PC1 (0.47) | CHRM4CHRM3 | |
| SCHEMBL15440298 | 0.72 | G6PC1 (0.47) | CHRM4CHRM3 | |
| SCHEMBL15438775 | 0.71 | NPC1 (0.44) | — | |
| SCHEMBL15438772 | 0.71 | NPC1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9115231-B2 | Polymers functionalized with protected hydrazone compounds containing an acyl group | BRIDGESTONE CORPORATION (JP) | 2015-08-25 | — | — | US | disclosed |
| US-20140031488-A1 | Polymers Functionalized With Protected Hydrazone Compounds Containing An Acyl Group | BRIDGESTONE CORPORATION (JP) | 2014-01-30 | — | — | US | disclosed |